Document is current
Any future updates will be listed below
-
Authors
Vercruysse, François http://orcid.org/0000-0002-0874-0308
Barnetche, Thomas
Lazaro, Estibaliz
Shipley, Emilie
Lifermann, François
Balageas, Alexandre
Delbrel, Xavier
Fautrel, Bruno
Richez, Christophe
Schaeverbeke, Thierry
Truchetet, Marie-Elise
- License Information
-
More Information
Article History
Received: 27 August 2018
Accepted: 30 January 2019
First Online: 12 February 2019
Ethics approval and consent to participate
: Not applicable
: The authors state that they had full access to all the data in the study and they take responsibility for the integrity of the data and the accuracy of the data analysis as well as the decision to submit them for publication.
: François Vercruysse has no relevant relationship conditions or circumstances that present a potential conflict of interest regarding this study.Thomas Barnetche has no relevant relationships conditions or circumstances that present a potential conflict of interest regarding this study.Estibaliz Lazaro has received consultancy fees from Roche, Novartis, and UCB.Emilie Shipley has no relevant relationships conditions or circumstances that present a potential conflict of interest regarding this study.François Lifermann has no relevant relationships conditions or circumstances that present a potential conflict of interest regarding this study.Alexandre Balageas has no relevant relationships conditions or circumstances that present a potential conflict of interest regarding this study.Xavier Delbrel has no relevant relationships conditions or circumstances that present a potential conflict of interest regarding this study.Bruno Fautrel, Marie-Elise Truchetet, Christophe Richez, and Thierry Schaeverbeke have received consultancy fees and/or research funding from Abbvie, Bristol-Myers Squibb, Pfizer, Roche, Lilly, Novartis, and UCB.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
